Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

Deep immunophenotyping study characterizes advanced immune aging in individuals with Down syndrome

Feb. 4, 2022

Catalog of protein isoforms in blood cells can predict organ rejection

Feb. 2, 2022

Novel ester prodrugs of E-selectin antagonists with improved PK properties

Feb. 1, 2022

PDS-0202 universal flu vaccine neutralizes multiple strains of influenza in preclinical studies

Jan. 28, 2022

Shanghai Medicilon presents new S1PR1 modulators

Jan. 26, 2022

Hefei Amvite Pharmaceutical patents histamine H1 receptor antagonists

Jan. 26, 2022

Gene silencing using Toc-HDO technology ameliorated symptoms in EAE models

Jan. 21, 2022

Targeting specific behavioral immune traits of inflammation

Jan. 20, 2022

Medshine Discovery synthesizes new JAK3 inhibitors

Jan. 20, 2022

VelociT mouse model for analyzing T-cell function in human disease

Jan. 18, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
In the clinic for June 12, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Anixa, Beone, Bioinvent, Blossomhill, C4, Cellectis, Climb, Elixiron,...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...